FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

35906611000001103: Tildrakizumab (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    110904401000001114 Tildrakizumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    110904501000001113 Tildrakizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Tildrakizumab Is a Monoclonal antibody false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Tildrakizumab 100mg/1ml solution for injection pre-filled syringes Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier
    Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier
    Tildrakizumab 100mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier
    Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) 1 pre-filled disposable injection Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier
    Tildrakizumab 100mg/1ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier
    Ilumetri 100mg/1ml solution for injection pre-filled syringes (Almirall Ltd) 2 pre-filled disposable injection Has specific active ingredient False Tildrakizumab Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start